Type 2 & other diabetes

Sustained metabolic improvements in a remotely delivered ketogenic nutrition programme for veterans with type 2 diabetes: A 3‐year observational study

Diabetes Obes MetabPublished Retrospective observational study

Authors' conclusion

For US Veterans, long-term participation in a remote ketogenic nutrition therapy intervention was associated with sustained improvements in glycaemic control, weight, medication use and select cardiometabolic markers. A 0.8% HbA1c reduction is associated with meaningful reductions in diabetes-related complications, highlighting the potential clinical relevance of these findings.

Study context

Population
Veterans with T2D in a remote, medically supervised ketogenic nutrition therapy intervention; mean age 59 years, BMI 35 kg/m², HbA1c 8.4%enrolled
Participants
640 veterans
Outcome
HbA1c, weight, diabetes medication use and cardiometabolic markers (lipids, liver enzymes, kidney function) among those enrolled for 2 or 3 years
Follow-up
2 and 3 years
Methodological detailsremote continuous care intervention, de-identified medical records
  • Remote continuous care intervention
  • De-identified medical records

Main finding

As reported in the abstract

Remained engaged at 2 years

310

49%

Remained engaged at 3 years

197

33%

HbA1c reduction at both time points

≈0.8%

Weight decrease at both 2 and 3 years

≈9%

Observational data: associations, not effects.

Further findings

Subgroups

Reductions in HbA1c and weight seen across subgroups overall

Veterans who discontinued before 2 years · programme departure

Metabolic improvements, with greater benefits among those enrolled at least 6 months

Original publication

Sustained metabolic improvements in a remotely delivered ketogenic nutrition programme for veterans with type 2 diabetes: A 3‐year observational study. Diabetes Obes Metab. Published 16 June 2025. doi:10.1111/dom.16525

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.